KOR

e-Article

Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience
Document Type
Article
Source
In: Leukemia and Lymphoma. (Leukemia and Lymphoma, 29 July 2019, 60(9):2223-2229)
Subject
Language
English
ISSN
10292403
10428194